A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT07550842 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07550842
- Sponsor
- Shanghai Best-Link Bioscience, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2028-04-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.